SYNT Stock Overview
Synthomer plc operates as a specialty chemicals company.
+ 1 more risk
Price History & Performance
|Historical stock prices|
|Current Share Price||UK£2.11|
|52 Week High||UK£5.71|
|52 Week Low||UK£1.82|
|1 Month Change||-8.33%|
|3 Month Change||-27.00%|
|1 Year Change||-62.28%|
|3 Year Change||-27.95%|
|5 Year Change||-55.60%|
|Change since IPO||-6.46%|
Recent News & Updates
|SYNT||GB Chemicals||GB Market|
Return vs Industry: SYNT underperformed the UK Chemicals industry which returned -28% over the past year.
Return vs Market: SYNT underperformed the UK Market which returned -11.2% over the past year.
|SYNT Average Weekly Movement||6.5%|
|Chemicals Industry Average Movement||6.6%|
|Market Average Movement||5.4%|
|10% most volatile stocks in GB Market||10.8%|
|10% least volatile stocks in GB Market||2.7%|
Stable Share Price: SYNT is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: SYNT's weekly volatility (7%) has been stable over the past year.
About the Company
Synthomer plc operates as a specialty chemicals company. It operates through four segments: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers. The company offers pressure sensitive adhesives, acrylic polymers, acrylic dispersions, saturants, release coatings, and other adhesives; water-based carboxylated styrene butadiene rubber, redispersible powder, flooring adhesive, and additives for construction applications; and impregnation binders, styrene butadiene copolymers, dispersions, polymer binders, and butadiene-based binders for textiles applications.
Synthomer Fundamentals Summary
|SYNT fundamental statistics|
Is SYNT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SYNT income statement (TTM)|
|Cost of Revenue||UK£1.88b|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.20|
|Net Profit Margin||3.85%|
How did SYNT perform over the long term?See historical performance and comparison
12.0%Current Dividend Yield
Does SYNT pay a reliable dividends?See SYNT dividend history and benchmarks
|Synthomer dividend dates|
|Ex Dividend Date||Oct 06 2022|
|Dividend Pay Date||Nov 04 2022|
|Days until Ex dividend||56 days|
|Days until Dividend pay date||85 days|
Does SYNT pay a reliable dividends?See SYNT dividend history and benchmarks
Is SYNT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 5/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SYNT?
Other financial metrics that can be useful for relative valuation.
|What is SYNT's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does SYNT's PE Ratio compare to its peers?
|SYNT PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
JMAT Johnson Matthey
Price-To-Earnings vs Peers: SYNT is good value based on its Price-To-Earnings Ratio (10.5x) compared to the peer average (33.6x).
Price to Earnings Ratio vs Industry
How does SYNT's PE Ratio compare vs other companies in the European Chemicals Industry?
Price-To-Earnings vs Industry: SYNT is good value based on its Price-To-Earnings Ratio (10.5x) compared to the UK Chemicals industry average (25.3x)
Price to Earnings Ratio vs Fair Ratio
What is SYNT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||10.5x|
|Fair PE Ratio||14.5x|
Price-To-Earnings vs Fair Ratio: SYNT is good value based on its Price-To-Earnings Ratio (10.5x) compared to the estimated Fair Price-To-Earnings Ratio (14.6x).
Share Price vs Fair Value
What is the Fair Price of SYNT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SYNT (£2.11) is trading below our estimate of fair value (£3.05)
Significantly Below Fair Value: SYNT is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
How is Synthomer forecast to perform in the next 1 to 3 years based on estimates from 13 analysts?
Future Growth Score3/6
Future Growth Score 3/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SYNT's forecast earnings growth (12.7% per year) is above the savings rate (0.9%).
Earnings vs Market: SYNT's earnings (12.7% per year) are forecast to grow faster than the UK market (9.8% per year).
High Growth Earnings: SYNT's earnings are forecast to grow, but not significantly.
Revenue vs Market: SYNT's revenue (4.6% per year) is forecast to grow faster than the UK market (4% per year).
High Growth Revenue: SYNT's revenue (4.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SYNT's Return on Equity is forecast to be low in 3 years time (16.2%).
Discover growth companies
How has Synthomer performed over the past 5 years?
Past Performance Score1/6
Past Performance Score 1/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SYNT has a large one-off loss of £76.7M impacting its June 30 2022 financial results.
Growing Profit Margin: SYNT's current net profit margins (3.9%) are lower than last year (10.1%).
Past Earnings Growth Analysis
Earnings Trend: SYNT's earnings have grown by 12.5% per year over the past 5 years.
Accelerating Growth: SYNT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: SYNT had negative earnings growth (-56.7%) over the past year, making it difficult to compare to the Chemicals industry average (-17.8%).
Return on Equity
High ROE: SYNT's Return on Equity (8.4%) is considered low.
Discover strong past performing companies
How is Synthomer's financial position?
Financial Health Score2/6
Financial Health Score 2/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: SYNT's short term assets (£1.3B) exceed its short term liabilities (£833.2M).
Long Term Liabilities: SYNT's short term assets (£1.3B) do not cover its long term liabilities (£1.4B).
Debt to Equity History and Analysis
Debt Level: SYNT's net debt to equity ratio (87.5%) is considered high.
Reducing Debt: SYNT's debt to equity ratio has increased from 103.3% to 110.7% over the past 5 years.
Debt Coverage: SYNT's debt is not well covered by operating cash flow (9.8%).
Interest Coverage: SYNT's interest payments on its debt are well covered by EBIT (8.4x coverage).
Discover healthy companies
What is Synthomer current dividend yield, its reliability and sustainability?
Dividend Score 3/6
Cash Flow Coverage
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: SYNT's dividend (11.97%) is higher than the bottom 25% of dividend payers in the UK market (1.85%).
High Dividend: SYNT's dividend (11.97%) is in the top 25% of dividend payers in the UK market (5.17%)
Stability and Growth of Payments
Stable Dividend: SYNT's dividend payments have been volatile in the past 10 years.
Growing Dividend: SYNT's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (122.3%), SYNT's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (327.5%), SYNT's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Michael Willome (56 yo)
Mr. Michael Willome, lic. oec. HSG serves as the Chief Executive Officer at Synthomer plc since November 1, 2021 and serves as its Executive Director since 2021.He had been Group Chief Executive Officer o...
CEO Compensation Analysis
Compensation vs Market: Michael's total compensation ($USD967.35K) is below average for companies of similar size in the UK market ($USD1.97M).
Compensation vs Earnings: Insufficient data to compare Michael's compensation with company performance.
Experienced Management: SYNT's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Experienced Board: SYNT's board of directors are considered experienced (3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10%.
Synthomer plc's employee growth, exchange listings and data sources
- Name: Synthomer plc
- Ticker: SYNT
- Exchange: LSE
- Founded: 1863
- Industry: Specialty Chemicals
- Sector: Materials
- Implied Market Cap: UK£912.702m
- Shares outstanding: 467.33m
- Website: https://www.synthomer.com
Number of Employees
- Synthomer plc
- 45 Pall Mall
- Greater London
- SW1Y 5JG
- United Kingdom
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/10 00:00|
|End of Day Share Price||2022/08/10 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.